Introduction
Autoimmune diseases
Autoantibodies - Introduction
Autoantibodies - Determination
 
Autoantibodies
Rheumatoid Factor
Antinuclear Antibodies (ANA)
Specific Antibodies
Anti-neutrophil Cytoplasmic Antibodies
(ANCA)
Anti-phospholipid Antibodies
Anti-mitochondrial Antibodies (AMA)
Anti-endothelial Cell Antibodies (AECA)
Anti CCP antibodies
Antibodies against DNases
 
Quality Assurance
 
Reference ranges
 
Algorithm
ANA and incidence of diseases
Proposed stepwise diagnosis scheme
Positive Immunoflourescence -
Nucleoplasmic
Positive Immunoflourescence - Nucleolar
Positive Immunoflourescence -
Cytoplasmic
Type of autoimmune diseases
Conditions associated with antinuclear
antibodies (ANA)
 
Slide show
 
References
 
Collaborators
Specific Antibodies
Antiribonucleoprotein and anti-Sm
Antibodies to SS-A/Ro and SS-B/La
Anticentromere (ACA) and anti Scl-70 antibodies
Antibodies to anti-proliferating cell nuclear antigen (PCNA)
Antibodies to nuclear enzymes
PM-1 in polymyositis
DNA antibodies
Antibodies to histones
 
Antibodies to histones - Introduction

Autoantibodies reactive with denatured histones and with epitopes requiring the native histone-DNA structure in chromatin have been measured by many techniques. The presence of antichromatin antibodies is useful in diagnosing SLE and in diagnosing lupus induced by procainamide and certain other drugs such as quinidine, isoniazid, sulfasalazine and acebutolol (93). Appropriate antibodies have been reported in about 50% of patients with SLE and about 75% of patients with drug-induced lupus (29, 80). Especially, antibodies against histone-DNA complexes seem to be of some diagnostic value (94).

The amount of anti-histone antibodies might reflect disease activity, but they are not specific for SLE and can not differentiate between drug-induced and idiopathic SLE (90, 95).